ESSA Pharma Inc. (NASDAQ:EPIX – Get Free Report) (TSE:EPI) crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $5.93 and traded as low as $5.00. ESSA Pharma shares last traded at $5.37, with a volume of 89,307 shares traded.
ESSA Pharma Trading Down 6.4 %
The company has a market capitalization of $238.23 million, a PE ratio of -8.52 and a beta of 1.83. The business’s fifty day moving average is $5.93 and its two-hundred day moving average is $5.83.
ESSA Pharma (NASDAQ:EPIX – Get Free Report) (TSE:EPI) last announced its quarterly earnings data on Monday, August 5th. The company reported ($0.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.10. As a group, equities research analysts anticipate that ESSA Pharma Inc. will post -0.71 EPS for the current year.
Institutional Investors Weigh In On ESSA Pharma
ESSA Pharma Company Profile
ESSA Pharma Inc, a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company’s lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer.
Further Reading
- Five stocks we like better than ESSA Pharma
- Financial Services Stocks Investing
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Bank Stocks – Best Bank Stocks to Invest In
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Insider Trading – What You Need to Know
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for ESSA Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ESSA Pharma and related companies with MarketBeat.com's FREE daily email newsletter.